DynamX Bioadaptor

DEVICE2 trials

Sponsors

Elixir Medical Corporation, National Taiwan University Hospital

Conditions

Coronary Artery DiseaseIschemic Heart Disease

Unknown Phase

Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

Active, not recruitingNCT04562805

Elixir Medical CorporationCoronary Artery Disease, Ischemic Heart Disease

Start: 2020-09-30End: 2028-07-31Target: 2400Updated: 2024-10-16

Dynamic Change of Coronary Artery Curvature

CompletedNCT04936191

National Taiwan University HospitalCoronary Artery Disease

Start: 2022-11-18End: 2024-12-31Updated: 2025-01-07

Related Papers

Dynamic Change of Coronary Artery Geometry After Bioadaptor Implantation: A Single-blind Randomized Controlled Trial

Circulation Cardiovascular Interventions2026-01-29

Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.

2024-10-2815 citations

Percutaneous Coronary Intervention Using the DynamX Sirolimus‐Eluting Bioadaptor: 12‐Month Clinical and Imaging Outcomes

Journal of Interventional Cardiology2024-01-011 citations